Accellacare

Accellacare not only exceeds enrollment goals on our #obesity studies, we retain 92% of those patients. By offering patient centric services, like in-home visits and concierge services, we can reduce the patient and caregiver burden. Learn more: https://ow.ly/HLkr50SJ03L #patientretention #patient #accellacare

Accellacare offers experience in phase II-IV obesity studies involving most major drug classes including: GLP-1 receptor agonist, SGLT-2 inhibitors, DP-4 Inhibitors, Insulin and Insulin Analogs, and Alpha Glucosidase Inhibitors just to name a few. Learn more about our experience: https://ow.ly/BXOO50SIZS1

Accellacare consistently exceeds enrollment goals for obesity studies - on average, we enroll 129% of our #obesity study targets in under 4 months. Learn more: https://ow.ly/vPGs50SIZJl

Accellacare brings the expertise of more than 275 investigators globally with experience in treating diabetes, obesity and related comorbidities. Our Site Network offers access to a registered dietician and weight loss counseling. Learn more: https://lnkd.in/eaFYpfRW

Join our webinar on 9 July at 12 ET, "Ensuring patient recruitment at the site level." Accellacare presenters Melissa Gottschlich, Nicola McBeath, and Jessica Zuniga will discuss strategies to exceed enrollment targets at the site level, including assessing centralised vs. site-level support, site resourcing needs, barriers to patient centricity, and recruiting for a diverse patient population. Register here: https://ow.ly/6sTt50StCyO

Accellacare is experienced in obesity clinical trials, with 11 completed obesity studies to date. And as part of ICON, we have access to a team of experts in obesity research with more than 200 years’ experience on our leadership team alone. Learn more: https://lnkd.in/eeCV2rWZ

As part of ICON, we have access to a team of experts in vaccine research with more than 200 years’ experience on the leadership team alone, resulting in 18 EMA/FDA approved vaccines. Learn more from our team’s insights on vaccine research: https://lnkd.in/gnjamchW

Accellacare’s years of experience in vaccine research allows us the insight to exceed enrollment goals and bring potentially life-saving treatments to patients faster. Our vaccine experience includes COVID-19, flu, RSV and herpes studies. Message us to see how we can support your vaccine research: https://ow.ly/1OTY50RlVO7 #VaccinesWork

Accellacare is a proud supporter of #WorldImmunizationWeek. Every year, millions of lives are saved thanks to immunisations, which are widely recognized as one of the most effective human interventions. https://ow.ly/9iyo50RlVHq #VaccinesWork

Accellacare will be attending this year’s #DCT conference! Pass by booth #2 and meet our team of professionals and see how we can adapt our end-to-end services, operational model and technology to deliver customised solutions for your business. https://ow.ly/Xf4b50R8fRh